en

PRODUCT DETAIL

Aimovig 140 mg injekčný roztok v naplnenom pere

Code 1558D
MA number EU/1/18/1293/005
Product Form: sol inj 3 (3x1)x1 ml/140 mg (striek.inj.skl.v napl.pere)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 33 - ANTIMIGRAENICA,ANTISEROTONICA
ATC:
N NERVOUS SYSTEM
N02 ANALGESICS
N02C ANTIMIGRAINE PREPARATIONS
N02CD Calcitonin gene-related peptide (CGRP) antagonists
N02CD01 Erenumab
Shelf life: 36
Container: pre-filled syringe
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 26.07.2018
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 03.03.2023
eu-flag.png sk-flag.png